Erepdekinra is an interleukin-17A (IL-17A) receptor antagonist.
References:
[1]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical
References:
[1]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical